Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients
套细胞淋巴瘤患者接受布鲁顿酪氨酸激酶抑制剂伊布替尼治疗后，CD19(+)CD5(+)细胞迁移至外周血的情况
期刊:Blood
影响因子:23.1
doi:10.1182/blood-2013-02-482125
Chang, Betty Y; Francesco, Michelle; De Rooij, Martin F M; Magadala, Padmaja; Steggerda, Susanne M; Huang, Min Mei; Kuil, Annemieke; Herman, Sarah E M; Chang, Stella; Pals, Steven T; Wilson, Wyndham; Wiestner, Adrian; Spaargaren, Marcel; Buggy, Joseph J; Elias, Laurence
